{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:15:51Z","timestamp":1778998551112,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2016JJ6088"],"award-info":[{"award-number":["2016JJ6088"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010451","name":"Health and Family Planning Commission of Hunan Province","doi-asserted-by":"crossref","award":["B2016048"],"award-info":[{"award-number":["B2016048"]}],"id":[{"id":"10.13039\/501100010451","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13014-016-0739-y","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T14:13:52Z","timestamp":1496758432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["PET\/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma"],"prefix":"10.1186","volume":"12","author":[{"given":"Feng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-ping","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-qian","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-zhi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"issue":"2","key":"739_CR1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1470-2045(11)70320-5","volume":"13","author":"L Chen","year":"2012","unstructured":"Chen L, Hu CS, Chen XZ, et al. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patienasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2012;13(2):163\u201371.","journal-title":"Lancet Oncol"},{"issue":"1","key":"739_CR2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2016.01.040","volume":"374","author":"LL Tang","year":"2016","unstructured":"Tang LL, Chen WQ, Xue WQ, et al. Global trends in incidence and mortality of\u00a0nasopharyngeal carcinoma. Cancer Lett. 2016;374(1):22\u201330.","journal-title":"Cancer Lett"},{"issue":"3","key":"739_CR3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.oraloncology.2014.10.012","volume":"51","author":"J Zong","year":"2015","unstructured":"Zong J, Lin S, Lin J, Tang L, et al. Impact of intensity-modulated radiotherapy on\u2002nasopharyngeal carcinoma: validation of the 7th edition AJCC staging system. Oral Oncol. 2015;51(3):254\u20139.","journal-title":"Oral Oncol"},{"key":"739_CR4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1748-717X-8-157","volume":"8","author":"F Liu","year":"2013","unstructured":"Liu F, Xiao JP, Xu GZ, et al. Fractionated stereotactic radiotherapy for\u00a0136 patients with\u00a0locally\u00a0residual\u00a0nasopharyngeal\u00a0carcinoma. Radiat Oncol. 2013;8:157.","journal-title":"Radiat Oncol"},{"key":"739_CR5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ijrobp.2011.07.006","volume":"83","author":"S Qiu","year":"2012","unstructured":"Qiu S, Lin S, Tham IW, et al. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2012;83:676\u201383.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"739_CR6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.radonc.2006.03.012","volume":"79","author":"PM Teo","year":"2006","unstructured":"Teo PM, Leung SF, Tung SY, et al. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Radiother Oncol. 2006;79(1):27\u201333.","journal-title":"Radiother Oncol"},{"key":"739_CR7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1186\/1471-2407-14-894","volume":"14","author":"Y Ren","year":"2014","unstructured":"Ren Y, Zhao Q, Liu H, et al. 3D-image-guided HDR-brachytherapy\u2002versus 2D HDR-brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma. BMC Cancer. 2014;14:894.","journal-title":"BMC Cancer"},{"key":"739_CR8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1748-717X-9-67","volume":"9","author":"E Rosenblatt","year":"2014","unstructured":"Rosenblatt E, Abdel-Wahab M, El-Gantiry M, et al. Brachytherapy\u2002boost in loco-regionally advanced\u2002nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency. Radiat Oncol. 2014;9:67.","journal-title":"Radiat Oncol"},{"issue":"4","key":"739_CR9","volume":"10","author":"JS Wang","year":"2015","unstructured":"Wang JS, Zheng JN, Tang TY, et al. A\u00a0randomized\u00a0pilot\u00a0trial comparing Position Emission\u00a0Tomography\u2009(PET)-guided dose\u00a0escalation\u00a0radiotherapy to\u00a0conventional radiotherapy\u00a0in chemoradiotherapy treatment of locally advanced nasopharyngeal carcinoma. PLoS One. 2015;10(4), e0124018.","journal-title":"PLoS One"},{"issue":"1","key":"739_CR10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijrobp.2010.01.026","volume":"80","author":"RL Bakst","year":"2011","unstructured":"Bakst RL, Lee N, Pfister DG, et al. Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial. Int J Radiat Oncol Biol Phys. 2011;80(1):148\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"739_CR11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.radonc.2011.07.025","volume":"101","author":"G Delouya","year":"2011","unstructured":"Delouya G, Igidbashian L, Houle A, et al. 18F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer. Radiother Oncol. 2011;101(3):362\u20138.","journal-title":"Radiother Oncol"},{"issue":"2","key":"739_CR12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(11)70303-5","volume":"13","author":"NY Lee","year":"2012","unstructured":"Lee NY, Zhang Q, Pfister DG, et al. Addition\u00a0of bevacizumab\u00a0to\u00a0standard chemoradiation for\u00a0locoregionally\u00a0advanced\u00a0nasopharyngeal\u00a0carcinoma (RTOG\u00a00615): a phase 2 multi-institutional trial. Lancet Oncol. 2012;13(2):172\u201380.","journal-title":"Lancet Oncol"},{"issue":"22","key":"739_CR13","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","volume":"27","author":"NY Lee","year":"2009","unstructured":"Lee NY, Harris J, Garden AS, et al. Intensity-modulated radiation therapy with or without chemotherapy for\u2002nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009;27(22):3684\u201390.","journal-title":"J Clin Oncol"},{"issue":"3","key":"739_CR14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.radonc.2014.01.011","volume":"110","author":"S Lin","year":"2014","unstructured":"Lin S, Pan J, Han L, et al. Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin. Radiother Oncol. 2014;110(3):385\u20139.","journal-title":"Radiother Oncol"},{"issue":"23","key":"739_CR15","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/jnci\/djr432","volume":"103","author":"QY Chen","year":"2011","unstructured":"Chen QY, Wen YF, Guo L, et al. Concurrent chemoradiotherapy\u00a0vs radiotherapy alone\u00a0in\u00a0stage\u00a0II\u00a0nasopharyngeal carcinoma:\u2009phase\u00a0III randomized trial. J Natl Cancer Inst. 2011;103(23):1761\u201370.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"739_CR16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.oraloncology.2015.06.008","volume":"51","author":"T Xu","year":"2015","unstructured":"Xu T, Liu Y, Dou S, et al. Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in\u2002locally advanced nasopharyngeal carcinoma: results of a randomized phase II study. Oral Oncol. 2015;51(9):875\u20139.","journal-title":"Oral Oncol"},{"issue":"8","key":"739_CR17","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.oraloncology.2015.05.006","volume":"51","author":"YQ Song","year":"2015","unstructured":"Song YQ, Wang WW, Tao GZ, et al. Survival benefit of induction chemotherapy in treatment for locally advanced nasopharyngeal carcinoma \u2013 a time-to-event meta-analysis. Oral Oncol. 2015;51(8):764\u20139.","journal-title":"Oral Oncol"},{"issue":"3","key":"739_CR18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.radonc.2014.02.017","volume":"111","author":"LA Olteanu","year":"2014","unstructured":"Olteanu LA, Berwouts D, Madani I, et al. Comparative dosimetry of three-phase adaptive and non-adaptive\u2002dose-painting\u2002IMRT for head-and-neck cancer. Radiother Oncol. 2014;111(3):348\u201353.","journal-title":"Radiother Oncol"},{"issue":"9","key":"739_CR19","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3109\/0284186X.2015.1061694","volume":"54","author":"JH Rasmussen","year":"2015","unstructured":"Rasmussen JH, Vogelius IR, Aznar MC, et al. Spatio-temporal stability of pre-treatment 18\u00a0F-Fludeoxyglucose uptake in\u2002head\u2002and\u2002neck\u2002squamous cell carcinomas sufficient for\u2002dose painting. Acta Oncol. 2015;54(9):1416\u201322.","journal-title":"Acta Oncol"},{"issue":"2","key":"739_CR20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/0284186X.2015.1046997","volume":"55","author":"S Differding","year":"2016","unstructured":"Differding S, Sterpin E, Janssens G, et al. Methodology for adaptive and robust FDG-PET escalated\u2002dose painting\u2002by numbers in\u2002head\u2002andneck\u2002tumors. Acta Oncol. 2016;55(2):217\u201325.","journal-title":"Acta Oncol"},{"issue":"3","key":"739_CR21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2013.04.002","volume":"107","author":"D Berwouts","year":"2013","unstructured":"Berwouts D, Olteanu LA, Duprez F, et al. Three-phase adaptive dose-painting-by-numbers for\u2002head-and-neck\u2002cancer: initial results of the phase I clinical trial. Radiother Oncol. 2013;107(3):310\u20136.","journal-title":"Radiother Oncol"},{"issue":"2","key":"739_CR22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.radonc.2013.01.003","volume":"106","author":"AC Houweling","year":"2013","unstructured":"Houweling AC, Wolf AL, Vogel WV, et al. FDG-PET and diffusion-weighted MRI in\u2002head-and-neck\u2002cancer patients: implications for\u2002dose painting. Radiother Oncol. 2013;106(2):250\u20134.","journal-title":"Radiother Oncol"},{"issue":"2","key":"739_CR23","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ijrobp.2011.07.037","volume":"83","author":"LA Olteanu","year":"2012","unstructured":"Olteanu LA, Madani I, De Neve W, et al. Evaluation of deformable image coregistration in adaptive\u00a0dose painting\u00a0by numbers for\u00a0head-and-neck\u00a0cancer. Int J Radiat Oncol Biol Phys. 2012;83(2):696\u2013703.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"739_CR24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.radonc.2016.03.005","volume":"120","author":"JH Rasmussen","year":"2016","unstructured":"Rasmussen JH, Hakansson K, Vogelius IR, et al. Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer. Radiother Oncol. 2016;120(1):76\u201380.","journal-title":"Radiother Oncol"},{"issue":"2","key":"739_CR25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/0284186X.2015.1046997","volume":"55","author":"S Differding","year":"2016","unstructured":"Differding S, Sterpin E, Janssens G, et al. Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors. Acta Oncol. 2016;55(2):217\u201325.","journal-title":"Acta Oncol"},{"issue":"3","key":"739_CR26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.radonc.2011.06.020","volume":"101","author":"I Madani","year":"2011","unstructured":"Madani I, Duprez F, Boterberg T, et al. Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer. Radiother Oncol. 2011;101(3):351\u20135.","journal-title":"Radiother Oncol"},{"issue":"5","key":"739_CR27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/0194599813496537","volume":"149","author":"J Hong","year":"2013","unstructured":"Hong J, Yao Y, Yu Z, et al. Value of magnetic resonance diffusion-weighted imaging for the prediction of radiosensitivity in nasopharyngeal carcinoma. Otolaryngol Head Neck Surg. 2013;149(5):707\u201313.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"739_CR28","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2015.08.003","volume":"93","author":"LT Liu","year":"2015","unstructured":"Liu LT, Tang LQ, Chen QY, et al. The prognostic value of plasma epstein-barr viral DNA and tumor response to neoadjuvant chemotherapy in advanced-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2015;93(4):862\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"739_CR29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12885-016-2148-x","volume":"16","author":"Y He","year":"2016","unstructured":"He Y, Wang Y, Shen L, et al. Prognostic value of the distance between the primary tumor and brainstem in the patients with locally advanced nasopharyngeal carcinoma. BMC Cancer. 2016;16(1):114.","journal-title":"BMC Cancer"},{"issue":"2","key":"739_CR30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2009.04.043","volume":"75","author":"H Yu","year":"2009","unstructured":"Yu H, Caldwell C, Mah K, et al. Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images. Int J Radiat Oncol Biol Phys. 2009;75(2):618\u201325.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"739_CR31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijrobp.2008.05.023","volume":"73","author":"AW Lee","year":"2009","unstructured":"Lee AW, Ng WT, Hung WM, et al. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient-and treatment-related risk factors. Int J Radiat Oncol Biol Phys. 2009;73(4):1121\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"739_CR32","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1200\/JCO.2012.46.0816","volume":"31","author":"LQ Tang","year":"2013","unstructured":"Tang LQ, Chen QY, Fan W, et al. Prospective study of tailoring whole-body dual-modality [18\u00a0F]fluorodeoxyglucose positron emission tomography\/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol. 2013;31(23):2861\u20139.","journal-title":"J Clin Oncol"},{"issue":"34","key":"739_CR33","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1200\/JCO.2006.07.7982","volume":"24","author":"SF Leung","year":"2006","unstructured":"Leung SF, Zee B, Ma BB, et al. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. J Clin Oncol. 2006;24(34):5414\u20138.","journal-title":"J Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-016-0739-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T23:43:56Z","timestamp":1589759036000},"score":1,"resource":{"primary":{"URL":"http:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-016-0739-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1186\/s13014-016-0739-y","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]},"article-number":"15"}}